NCT05299034

Brief Summary

We aim to optimize the radiological selection and the transfer model in patients with a 6-24h stroke for a fairer and broader access to a reperfusion treatment. The specific objectives are:

  1. 1.To confirm that the selection of patients for reperfusion therapies in the late window is safe by applying the same clinical and imaging criteria recommended by clinical guidelines for the early window treatment selection.
  2. 2.To evaluate the performance of non-contrast CT by applying immediate post-processing software for the selection of patients for reperfusion treatment in the late window.
  3. 3.To analyze the prehospital and arrival variables at the primary stroke center to generate decision trees that optimize the transfer decision in patients with activation of the stroke code in \>6h from the onset of symptoms.
  4. 4.retrospective analysis with a detailed evaluation of the images of the included patients and generation of "machine learning" models that accurately predict the probability of receiving reperfusion treatment in the late window.
  5. 5.validation of the models in a prospective study. Clinical, radiological and transport variables will be studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,173

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

January 14, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

1.6 years

First QC Date

January 13, 2022

Last Update Submit

August 18, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • mRS at 90 days

    Percentage of patients with functional independence, defined as mRS \< or =2 on day 90 as assessed centrally by blinded evaluators of the Catalan Stroke Master Plan.

    90 days after stroke

  • Rate of patients treated with mechanical thrombectomy

    less than 24 hours after the diagnostic test

Secondary Outcomes (2)

  • Mortality at discharge and at day 90

    90 days after stroke

  • Symptomatic intracerebral hemorrhage, defined as PH2 or SAH on imaging test at 24-72 hours associated with a worsening in NIHSS ≥ 4 points

    From 24 to 72 hours after stroke

Study Arms (2)

Stroke patients 6-24h receiving non-contrast CT + CTA

Stroke patients 6-24h undergoing non-contrast CT + CTA to decide stroke therapy

Diagnostic Test: Non contrast CT+CT angiography

Stroke patients 6-24h receiving multimodal imaging

Stroke patients 6-24h undergoing NCCT+CTA+CTP or MRI with DWI and PWI imaging to decide stroke therapy

Diagnostic Test: Multiparametric imaging

Interventions

MR perfusion or multiparametric CT including NCCT, CTA and CTP

Stroke patients 6-24h receiving multimodal imaging

NCCT+CTA

Stroke patients 6-24h receiving non-contrast CT + CTA

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with stroke suspiction in Catalonia included in the CICAT registry

You may qualify if:

  • Age older than 18 years,
  • Diagnosis of acute cerebral infarction,
  • More than six hours of evolution or uncertain chronology of symptoms,
  • Absence of disability prior to stroke (modified Rankin score 0-2),
  • NIHSS score\>5,
  • Neuroimaging study including at least one non-contrast cranial CT scan within 60 minutes of arrival at the hospital center.
  • SUBSTUDY 2. OPTIMIZATION OF CIRCUITS AND TRANSFER MODEL IN PATIENTS WITH STROKE IN THE EXTENDED WINDOW OF TREATMENT.
  • Age over 18 years,
  • Suspicion of acute cerebral infarction,
  • More than six hours of evolution or uncertain chronology of symptoms,
  • absence of pre-stroke disability (modified Rankin score 0-2),
  • NIHSS score greater than 5.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Germans Trias i Pujol Hospital

Badalona, Barcelona, 08916, Spain

Location

MeSH Terms

Conditions

Ischemic Stroke

Interventions

Multiparametric Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Resonance ImagingTomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

January 13, 2022

First Posted

March 28, 2022

Study Start

January 14, 2022

Primary Completion

August 15, 2023

Study Completion

August 15, 2023

Last Updated

August 22, 2023

Record last verified: 2023-08

Locations